Successful treatment of bone marrow transplant-associated thrombotic microangiopathy with antithrombin-III [4]

American Journal of Medicine

Volumn 112, Issue 1, 2002, Pages 81-82

  Mori, Takehiko ^a   Okamoto, Shinichiro ^a   Watanabe, Reiko ^a   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; CYCLOSPORIN A; METHOTREXATE; TACROLIMUS;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; BONE MARROW TRANSPLANTATION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; COOMBS TEST; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; ANTITHROMBIN III; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; LEUKEMIA; THROMBOCYTOPENIA;

EID: 0036152641     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00947-0     Document Type: Letter

References (9)

1. Thrombotic microangiopathy following bone marrow transplantation
2. Bone marrow transplant-associated microangiopathy: A case series
3. Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy: A case series
4. Management of thrombotic microangiopathy following allogeneic transplantation: What is the role of plasma exchange
5. Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III
6. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin
7. Effects of antithrombin III (ATIII) and TRP49-modified AT III on plasma level of 6-keto-PGF1α in rats
8. Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation
9. Effects of various doses of antithrombin III on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats